IFM Investors Pty Ltd Buys Shares of 7,630 National Health Investors, Inc. $NHI

IFM Investors Pty Ltd purchased a new stake in National Health Investors, Inc. (NYSE:NHI) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 7,630 shares of the real estate investment trust’s stock, valued at approximately $617,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. NewEdge Advisors LLC lifted its holdings in National Health Investors by 28.7% in the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after acquiring an additional 345 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock valued at $18,460,000 after purchasing an additional 21,851 shares during the period. Jane Street Group LLC raised its position in National Health Investors by 1,728.4% in the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after purchasing an additional 65,885 shares during the period. Cetera Investment Advisers lifted its stake in shares of National Health Investors by 6.1% in the 2nd quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock valued at $336,000 after purchasing an additional 275 shares during the last quarter. Finally, American Century Companies Inc. grew its holdings in shares of National Health Investors by 2.2% during the 2nd quarter. American Century Companies Inc. now owns 19,236 shares of the real estate investment trust’s stock worth $1,349,000 after purchasing an additional 420 shares during the period. Institutional investors and hedge funds own 62.51% of the company’s stock.

Insider Transactions at National Health Investors

In other National Health Investors news, Director Robert A. Mccabe, Jr. acquired 890 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the acquisition, the director owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO D. Eric Mendelsohn bought 1,500 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The shares were acquired at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the purchase, the chief executive officer owned 133,316 shares in the company, valued at $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 2.70% of the stock is owned by corporate insiders.

National Health Investors Trading Down 0.1%

Shares of NYSE NHI opened at $77.44 on Monday. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $3.75 billion, a PE ratio of 24.98, a PEG ratio of 3.48 and a beta of 0.51. National Health Investors, Inc. has a twelve month low of $67.94 and a twelve month high of $91.38. The stock has a fifty day simple moving average of $74.27 and a 200-day simple moving average of $79.64.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be given a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 4.8%. The ex-dividend date of this dividend is Tuesday, June 30th. National Health Investors’s payout ratio is currently 118.71%.

Analysts Set New Price Targets

A number of analysts recently issued reports on NHI shares. Weiss Ratings downgraded National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Truist Financial decreased their target price on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research report on Friday, June 12th. BMO Capital Markets lowered their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research note on Monday, June 15th. Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 25th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research note on Thursday, June 25th. Five equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $83.86.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.